TARIBO trial: Cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with targeted agents

被引：1
|
作者：
Grassi, Paolo
Verzoni, Elena
Bearz, Alessandra
Bracarda, Sergio
Bregni, Marco
Buti, Sebastiano
Cinieri, Saverio
De Giorgi, Ugo
Fornarini, Giuseppe
Galli, Luca
Milella, Michele
Morelli, Franco
Nole, Franco
Passalacqua, Rodolfo
Sabbatini, Roberto
Santini, Daniele
Salvioni, Roberto
Cappelletti, Vera
Ratta, Raffaele
Procopio, Giuseppe
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] IRCCS Ctr Rif Oncol, Aviano, Italy
[3] Osped San Donato Azienda USL 8, Perugia, Italy
[4] Osped Circolo, Busto Arsizio, Italy
[5] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[6] ASL Brindisi, Dept Oncol, Brindisi, Italy
[7] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy
[8] Osped San Martino Genova, Med Oncol, Genoa, Italy
[9] Azienda Osped Univ Pisana, Pisa, Italy
[10] Regina Elena Inst Canc Res, Med Oncol, Rome, Italy
[11] UOC Oncol, IRCCS Caa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[12] European Inst Oncol, Med Oncol Div Urogenital & Head & Neck Tumors, Milan, Italy
[13] ASST Cremona, Oncol Unit, Cremona, Italy
[14] Univ Hosp Policlin Modena, Modena, Italy
[15] Univ Campus Biomed, Dept Med Oncol, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.TPS4601
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4601
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
    Song Yan
    Du Chun-Xia
    Zhang Wen
    Sun Yong-Kun
    Yang Lin
    Cui Cheng-Xu
    Chi Yihe-Bali
    Shou Jian-Zhong
    Zhou Ai-Ping
    Li Chang-Ling
    Ma Jian-Hui
    Wang Jin-Wan
    Sun Yan
    中华医学杂志英文版, 2016, 129 (05) : 530 - 535
  • [2] Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy
    Richey, S. L.
    Culp, S. H.
    Jonasch, E.
    Corn, P. G.
    Pagliaro, L. C.
    Tamboli, P.
    Patel, K. K.
    Matin, S. F.
    Wood, C. G.
    Tannir, N. M.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1048 - 1053
  • [3] Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
    Song, Yan
    Du, Chun-Xia
    Zhang, Wen
    Sun, Yong-Kun
    Yang, Lin
    Cui, Cheng-Xu
    Chi, Yihe-Bali
    Shou, Jian-Zhong
    Zhou, Ai-Ping
    Li, Chang-Ling
    Ma, Jian-Hui
    Wang, Jin-Wan
    Sun, Yan
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 530 - 535
  • [4] Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents
    Jun Teishima
    Keisuke Goto
    Yohei Sekino
    Koji Mita
    Tetsutaro Hayashi
    Yasuhisa Hasegawa
    Masao Kato
    Mitsuru Kajiwara
    Masanobu Shigeta
    Satoshi Maruyama
    Yuichi Kadonishi
    Seiji Fujiwara
    Kanao Kobayashi
    Kousuke Asano
    Nobuyuki Hinata
    International Urology and Nephrology, 2022, 54 : 1225 - 1232
  • [5] Prognostic model of upfront cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors and/or targeted agents
    Teishima, Jun
    Goto, Keisuke
    Sekino, Yohei
    Mita, Koji
    Hayashi, Tetsutaro
    Hasegawa, Yasuhisa
    Kato, Masao
    Kajiwara, Mitsuru
    Shigeta, Masanobu
    Maruyama, Satoshi
    Kadonishi, Yuichi
    Fujiwara, Seiji
    Kobayashi, Kanao
    Asano, Kousuke
    Hinata, Nobuyuki
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (06) : 1225 - 1232
  • [6] TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery
    Verzoni, Elena
    Ratta, Raffaele
    Grassi, Paolo
    Salvioni, Roberto
    Stagni, Silvia
    Montone, Rosanna
    Fuca, Giovanni
    Cappelletti, Vera
    Reduzzi, Carolina
    De Giorgi, Ugo
    Procopio, Giuseppe
    TUMORI JOURNAL, 2018, 104 (05): : 401 - 405
  • [7] Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era
    Uprety, Dipesh
    Bista, Amir
    Smith, Angela L.
    Vallatharasu, Yazhini
    Marinier, David E.
    ANTICANCER RESEARCH, 2018, 38 (05) : 3013 - 3018
  • [8] TARIBO trial: Targeted therapy with or without nephrectomy in metastatic renal cell carcinoma (mRCC)-Liquid biopsy for biomarkers discovery
    Verzoni, Elena
    Bearz, Alessandra
    Bracarda, Sergio
    Bregni, Marco
    Buti, Sebastiano
    Cinieri, Saverio
    De Giorgi, Ugo
    Fornarini, Giuseppe
    Galli, Luca
    Milella, Michele
    Morelli, Franco
    Nole, Franco
    Passalacqua, Rodolfo
    Sabbatini, Roberto
    Santini, Daniele
    Salvioni, Roberto
    Cappelletti, Vera
    Grassi, Paolo
    De Braud, Filippo G.
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025,
  • [10] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025, 19 (06) : 215 - 222
12345